ARCA biopharma (ABIO) Stock Price, News & Analysis
Company Description
ARCA biopharma (NASDAQ: ABIO) is classified in the pharmaceutical preparation manufacturing industry within the In Vitro & in Vivo Diagnostic Substances sector and carries a market capitalization of $34.8M, ranking #5,996 among all listed U.S. companies by market cap.
This page collects what Stock Titan holds for ABIO, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
ARCA biopharma (ABIO) stock last closed at $2.40. At a market capitalization of $34.8M, ABIO is classified as a micro-cap stock with approximately 14.5M shares outstanding.
ABIO Rankings
Latest News
ARCA biopharma has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include stock split, acquisition, dividends, earnings. View all ABIO news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ABIO Company Profile & Sector Positioning
ARCA biopharma (ABIO) operates in the Pharmaceutical Preparation Manufacturing industry within the broader In Vitro & in Vivo Diagnostic Substances sector and is listed on the NASDAQ.